In TCGA datasets, there was positive correlation between PDIA5 and CD276 or PDCD1LG2 in pan-glioma patients, and PDIA5 expression was positively associated with CD276, PDCD1LG2 and HAVCR2 in LGG patients. This evidence concerns the gene PDIA5 and central nervous system cancer.